BAI-2 inhibitors belong to a distinctive chemical class renowned for their role in modulating a specific biological target, the Brain-specific Angiogenesis Inhibitor 2 (BAI-2). These inhibitors are designed with precision to interact with the BAI-2 protein, a member of the adhesion G protein-coupled receptor (GPCR) family. Adhesion GPCRs are a diverse group of cell surface receptors implicated in various physiological processes, and BAI-2, in particular, is notable for its involvement in angiogenesis regulation within the central nervous system. The chemical structure of BAI-2 inhibitors is characterized by its capacity to bind selectively to the active site of the BAI-2 protein, thereby modulating its signaling pathways.
BAI-2 inhibitors involves a careful consideration of the molecular interactions occurring at the binding site. These inhibitors typically possess specific functional groups and structural motifs that facilitate a high-affinity interaction with the target protein, ensuring a robust and selective inhibition of BAI-2 activity. Through this mechanism, BAI-2 inhibitors have the potential to influence angiogenesis processes in the brain, offering avenues for research and exploration in the context of neurobiology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
WZ811 | 55778-02-4 | sc-296701 sc-296701A | 1 mg 5 mg | $29.00 $66.00 | ||
Blocks the interaction between BAI-2 and G-protein-coupled receptors, inhibiting downstream signaling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, which is involved in angiogenesis that BAI-2 may regulate. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, a kinase that could be part of the signaling pathways involving BAI-2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, affecting signaling pathways that BAI-2 may influence. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, can disrupt pathways that BAI-2 might modulate. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
JAK2 inhibitor, potentially affecting signaling related to BAI-2's function. | ||||||
Met Kinase Inhibitor | 658084-23-2 | sc-204801 | 1 mg | $116.00 | 5 | |
MET inhibitor, could inhibit pathways associated with angiogenesis linked to BAI-2. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, could alter signaling pathways that include BAI-2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which may play a role in BAI-2 related pathways. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR inhibitor, could affect angiogenesis and related signaling pathways involving BAI-2. | ||||||